Clinical Safety

Genetic mapping of 10,000 Singaporeans reveals that nearly every citizen carries at least one genetic variant that negatively interacts with specific prescription medications. This startling statistic underscores a fundamental flaw in the traditional "one-size-fits-all" model of medicine, which has

Research indicates that high-value algorithms developed in academic settings often fail to diffuse to other hospitals due to the absence of a clear regulatory pathway for cross-institutional use. This bottleneck has created a landscape where groundbreaking tools remain siloed within the

Phase I clinical trials are currently evaluating the safety and efficacy of BI 1703880 in human patients with advanced solid tumors following successful preclinical validations. This breakthrough comes at a pivotal moment in oncology, as researchers strive to solve the disconnect between localized

Researchers at Mass General Brigham and the University of Chicago have demonstrated that it is possible to decouple therapeutic power from systemic toxicity in cellular immunotherapy. This clinical development addresses the long-standing challenge of multiple myeloma, a hematologic cancer that

A primary mission for the PSRM involves dismantling the 'magic bullet' myth by clarifying that regenerative medicine is a multifaceted field focused on long-term biological restoration. The Philippine Society of Regenerative Medicine (PSRM) was established at a pivotal moment in the nation's

The perceived efficiency of telehealth on a spreadsheet frequently masks the invisible labor required to manage medication loops from a distance. For facilities like St. Vincent’s Hospital in Sydney, Australia, the transition to digital pharmaceutical services was not merely a technological upgrade